NICE recommends first combination pill for long-term treatment of endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended the first daily pill to treat endometriosis for use on the NHS in England and Wales. In final draft guidance, published on 13 March 2025, NICE approved the pill, known as relugolix combination therapy or Ryeqo (Gedeon Richter), which contains relugolix — a non-peptide […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.350009
Primary Topic: Health Services Management and Policy
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

NICE recommends first combination pill for long-term treatment of endometriosis

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Health Services Management and Policy

article

NICE recommends first combination pill for long-term treatment of endometriosis

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Zero hunger

Openalex Percentile: Top 92%

Health Services Management and Policy

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NICE recommends first combination pill for long-term treatment of endometriosis · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS